The global custom antibody market, valued at USD 393.3 million in 2023, is driven by rising demand for personalised medicine and advancements in antibody production technologies. Expected to grow at a CAGR of 12.7% (2024-2032), the market will reach USD 1149.1 million by 2032. Key applicat